Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学BCMA-Targeted Myeloma Therapy

Sagar Lonial

MD

🏢Emory University Winship Cancer Institute🌐USA

Chief Medical Officer and Executive Vice President for Medical Affairs

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sagar Lonial is a leading myeloma expert who has been central to the development of BCMA-targeted therapies including belantamab mafodotin. His clinical research has defined the role of BCMA-directed ADCs, bispecifics, and CAR-T cells across treatment lines. He leads strategic initiatives to optimize sequencing of novel myeloma therapies.

Share:

🧪Research Fields 研究领域

Belantamab mafodotin
BCMA ADC
Myeloma treatment sequencing
Monoclonal antibody therapy
Clinical trial design myeloma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sagar Lonial 的研究动态

Follow Sagar Lonial's research updates

留下邮箱,当我们发布与 Sagar Lonial(Emory University Winship Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment